Cargando…
Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression
Previous studies have demonstrated that CTCs do not travel in the bloodstream alone, but rather are accompanied by clusters of stromal cells such as cancer associated fibroblasts (CAFs). Our laboratory has confirmed the presence of CAFs in the peripheral blood of prostate cancer (PC) patients. The o...
Autores principales: | Ortiz-Otero, Nerymar, Clinch, Andrea B., Hope, Jacob, Wang, Wenjun, Reinhart-King, Cynthia A., King, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105166/ https://www.ncbi.nlm.nih.gov/pubmed/32256977 http://dx.doi.org/10.18632/oncotarget.27510 |
Ejemplares similares
-
Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2020) -
Circulating prostate cancer cells have differential resistance to fluid shear stress-induced cell death
por: Hope, Jacob M., et al.
Publicado: (2021) -
Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
por: Grayson, Korie A., et al.
Publicado: (2021) -
TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2021) -
Platelet mediated TRAIL delivery for efficiently targeting circulating tumor cells
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2020)